glp-1 and bariatric surgery vs Study: 93.4% of Bariatric Patients Would Do the Surgery Again GLP-1 vs. Bariatric Surgery: 1-

Other studies performed in mice demonstrate that pancreatic Y1-R activation facilitates the trans-differentiation of -cells into -cells, thereby improving insulin sensitivity 21

Nevertheless, translating these experimental technologies into safe, effective, and commercially viable products requires extensive clinical trials to establish pharmacokinetics, bioavailability, efficacy, and safety profiles

WW claims that in a real-world comparative analysis, its members achieved 72% greater average weight loss than a cohort receiving compounded GLP-1 medications through Hims & Hers

Piccini S, Favacchio G, Panico C, Morenghi E, Folli F, Mazziotti G, et al